Turk Ilac ve Serum Sanayi AS
BBIST:TRILC0.85
TRY
+0.07
(+8.97%)
ISIN
TRETRLC00022
Return %
Stock
S&P 500
1Y
-73.32
14.20
3Y
-55.53
81.12
5Y
-48.41
68.34
Capital Structure
TRY
•
in mil. unless spec.Working Capital
TRY
•
in mil. unless spec.Growth Rates
TRY
•
in mil. unless spec.Quarterly Revenue
TRY
•
in mil. unless spec.Quarterly Earnings Per Share
TRY
•
in mil. unless spec.Quarterly Dividends Per Share
TRY
•
in mil. unless spec.Company Description
- CEO
- Yunus Emre Battal
- Full Time Employees
- 709
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Ankara Turkey
- IPO Date
- Mar 5, 2021
- Website
- turkilac.com.tr
- Similar Companies
- Business
- Turk Ilac ve Serum Sanayi AS is a Turkey-based pharmaceutical and healthcare manufacturing company that develops, produces, markets, and distributes sterile parenteral solutions, injectable pharmaceuticals, vaccines, and solid dosage formulations. Founded in 2010 and headquartered in Ankara, Turkey, the company operates an integrated 56,000-square-meter manufacturing complex in Akyurt, Ankara. The company organizes its core product portfolio into several primary categories: intravenous large-volume parenteral solutions under the TURKFLEKS brand, including isotonic sodium chloride, dextrose, balanced electrolyte, and Ringer's lactate infusions; small-volume parenterals, ampoules, and vials, featuring antiemetic injectable solutions such as KEMOTRON, antibiotic formulations like CEPAREN, and injectable anesthetics and analgesics; biological products and vaccines, notably the TETADIF tetanus toxoid vaccine and related immunobiological formulations; hemodialysis and peritoneal dialysis solutions; enteral and parenteral clinical nutrition formulations and amino acid complexes; solid and semi-solid oral pharmaceuticals, encompassing prescription tablets, capsules, ointments, and dermatological creams; and medical devices, chemical raw materials, and veterinary pharmaceuticals. In addition to proprietary manufacturing, the company provides contract manufacturing services, regulatory representation, and commercial agency services for domestic and international pharmaceutical enterprises. Turk Ilac ve Serum Sanayi AS serves public and private hospitals, clinical healthcare providers, and retail pharmacy networks across Turkey, acting as a primary supplier to the Turkish State Supply Office Health Market, while exporting products to international markets across Central Asia, the Middle East, Eastern Europe, and Africa. In recent operational and strategic developments, the company entered into an exclusive commercial partnership with CEO Pharma to manage the marketing and nationwide distribution of its prescription pharmaceutical portfolio across retail pharmacy channels; secured major international export supply contracts, including a multi-million-dollar supply agreement with the Ministry of Health and Medical Industry of Turkmenistan for critical hospital serums and medications; expanded procurement delivery volumes under recurring State Supply Office tenders for its core TURKFLEKS, KEMOTRON, and CEPAREN product lines; initiated plans to establish integrated pharmaceutical production joint ventures across select African markets; and implemented corporate and capital structure adjustments, including registered capital ceiling revisions and operational realignments under formal debt restructuring proceedings.